The Therapeutic Discovery Project (TDP) was enacted in 2010 to provide bridge financing to small biotechnology companies conducting groundbreaking research. The program awarded $1 billion in credits and grants to nearly 3,000 biotech companies, creating jobs, bolstering U.S. competitiveness, and advancing the search for cures and breakthrough medicines. BIO supports extending and expanding this important program.
Press Releases
February 15 2012
December 19 2011
September 19 2011
February 11 2011
January 26 2011
November 3 2010
October 28 2010
Letters, Testimony & Comments
April 1 2011
Re: Request for Comments on the Strategy for American Innovation
Subject: Innovation Strategy RFI
Email: competitiveness@doc.gov
Dear...
August 3 2010
SECTION 1. PURPOSE
This notice establishes the qualifying therapeutic discovery project program under § 48D of the Internal...
August 3 2010
BIO advocated for the recently enacted new Therapeutic Discovery Project Credit program, which was created as a unique opportunity for...
November 19 2009
As Congress considered healthcare reform patient advocacy groups submitted a letter to Congressional leadership asking for their support...
Press Releases
February 15 2012
Washington, DC (February 15, 2012) – Today, the Biotechnology Industry Organization (BIO) praised Sen. Kay...
December 19 2011
Extension of cellulosic biofuel tax credits now and eligibility for algae biofuels are needed to help companies raise...
September 19 2011
WASHINGTON, DC – (September 19, 2011) – The Biotechnology Industry Organization (BIO) today announced the...
May 25 2011
WASHINGTON, D.C. (Wednesday, May 25, 2011) - Biotechnology Industry Organization (BIO) President and CEO Jim...
May 4 2011
WASHINGTON, D.C. (Tuesday, May 04, 2011) - The Biotechnology Industry Organization (BIO) announced today its...
Receive our newsletter from BIOtechNOW
Business Solutions Sponsor
